StonvexLoading…
StonvexStonvexStonvexCore line items from FRST's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-07-22 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $41.55M | $53.53M | $200.44M | $147.12M | $95.35M |
Operating Income | Not available | $10.33M | $72.55M | $36.29M | $27.55M |
Net Income | Not available | $7.31M | $61.44M | $31.90M | $25.07M |
EPS (Diluted) | $0.37 | $0.30 | $2.49 | $1.29 | $1.01 |
Total Assets | Not available | $4.26B | $4.05B | $3.95B | $3.87B |
Total Liabilities | Not available | $3.83B | $3.62B | $3.57B | $3.50B |
Cash & Equivalents | Not available | $159.88M | $143.61M | $63.88M | $94.07M |
Free Cash Flow OCF − CapEx | Not available | $-54.57M | $9.03M | Not available | Not available |
Shares Outstanding | Not available | 24.77M | 24.70M | 24.64M | 24.64M |